Single Ascending Dose Study of NH102 in Healthy Subjects
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of
NH102 when administered as single oral dose at escalating dose levels in healthy
participants.